Mylan LLC.
Mylan LLC. appears in FDA public data with 5 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0441-2017, Class II) was initiated on December 20, 2016.
Summary
- Total Recalls
- 5
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Known Names
mylan, mylan pharmaceuticals, mylan special product line
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0441-2017 | Class II | Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98), b) 14-count bottle | December 20, 2016 |
| D-0444-2017 | Class II | Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV | December 20, 2016 |
| D-0443-2017 | Class II | Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottle | December 20, 2016 |
| D-0442-2017 | Class II | Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-98), b) 14-count bottle | December 20, 2016 |
| D-066-2013 | Class II | Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown | June 29, 2012 |